Literature DB >> 31871236

Influenza Hemagglutinin Structures and Antibody Recognition.

Nicholas C Wu1, Ian A Wilson1,2.   

Abstract

Hemagglutinin (HA) is most abundant glycoprotein on the influenza virus surface. Influenza HA promotes viral entry by engaging the receptor and mediating virus-host membrane fusion. At the same time, HA is the major antigen of the influenza virus. HA antigenic shift can result in pandemics, whereas antigenic drift allows human circulating strains to escape herd immunity. Most antibody responses against HA are strain-specific. However, antibodies that have neutralizing activities against multiple strains or even subtypes have now been discovered and characterized. These broadly neutralizing antibodies (bnAbs) target conserved regions on HA, such as the receptor-binding site and the stem domain. Structural studies of such bnAbs have provided important insight into universal influenza vaccine and therapeutic design. This review discusses the HA functions as well as HA-antibody interactions from a structural perspective.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31871236      PMCID: PMC7397844          DOI: 10.1101/cshperspect.a038778

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  189 in total

1.  Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses.

Authors:  Robert P de Vries; Xueyong Zhu; Ryan McBride; Alan Rigter; Anthony Hanson; Gongxun Zhong; Masato Hatta; Rui Xu; Wenli Yu; Yoshihiro Kawaoka; Cornelis A M de Haan; Ian A Wilson; James C Paulson
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.

Authors:  Terrence M Tumpey; Taronna R Maines; Neal Van Hoeven; Laurel Glaser; Alicia Solórzano; Claudia Pappas; Nancy J Cox; David E Swayne; Peter Palese; Jacqueline M Katz; Adolfo García-Sastre
Journal:  Science       Date:  2007-02-02       Impact factor: 47.728

3.  Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.

Authors:  Rui Xu; Ian A Wilson
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

4.  Stability of infectious influenza A viruses at low pH and at elevated temperature.

Authors:  C Scholtissek
Journal:  Vaccine       Date:  1985-09       Impact factor: 3.641

5.  Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities.

Authors:  Xueyong Zhu; Wenli Yu; Ryan McBride; Yan Li; Li-Mei Chen; Ruben O Donis; Suxiang Tong; James C Paulson; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

6.  Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.

Authors:  Joshua L Cherry; David J Lipman; Anastasia Nikolskaya; Yuri I Wolf
Journal:  PLoS Curr       Date:  2009-08-18

7.  A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.

Authors:  Ying Wu; MyungSam Cho; David Shore; Manki Song; JungAh Choi; Tao Jiang; Yong-Qiang Deng; Melissa Bourgeois; Lynn Almli; Hua Yang; Li-Mei Chen; Yi Shi; Jianxu Qi; An Li; Kye Sook Yi; MinSeok Chang; Jin Soo Bae; HyunJoo Lee; JiYoung Shin; James Stevens; SeoungSuh Hong; Cheng-Feng Qin; George F Gao; Shin Jae Chang; Ruben O Donis
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

8.  Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.

Authors:  Kevin R McCarthy; Akiko Watanabe; Masayuki Kuraoka; Khoi T Do; Charles E McGee; Gregory D Sempowski; Thomas B Kepler; Aaron G Schmidt; Garnett Kelsoe; Stephen C Harrison
Journal:  Immunity       Date:  2018-01-16       Impact factor: 43.474

9.  Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity.

Authors:  Meghan O Altman; Jack R Bennink; Jonathan W Yewdell; Brantley R Herrin
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

10.  The influenza virus hemagglutinin head evolves faster than the stalk domain.

Authors:  Ericka Kirkpatrick; Xueting Qiu; Patrick C Wilson; Justin Bahl; Florian Krammer
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

View more
  16 in total

1.  Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.

Authors:  Leerang Yang; Matthew Van Beek; Zijun Wang; Frauke Muecksch; Marie Canis; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig; Arup K Chakraborty
Journal:  bioRxiv       Date:  2022-08-25

Review 2.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

3.  N-Linked Glycosylation Plays an Important Role in Budding of Neuraminidase Protein and Virulence of Influenza Viruses.

Authors:  Danqi Bao; Ruixue Xue; Min Zhang; Chenyang Lu; Tianxin Ma; Chaochao Ren; Ting Zhang; Jianmei Yang; Qiaoyang Teng; Xuesong Li; Zejun Li; Qinfang Liu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 4.  Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.

Authors:  Charles J Russell
Journal:  Viruses       Date:  2021-04-24       Impact factor: 5.048

5.  Convergent Evolution in Breadth of Two VH6-1-Encoded Influenza Antibody Clonotypes from a Single Donor.

Authors:  Nicholas C Wu; Sarah F Andrews; Julie E Raab; Sarah O'Connell; Chaim A Schramm; Xintao Ding; Michael J Chambers; Kwanyee Leung; Lingshu Wang; Yi Zhang; John R Mascola; Daniel C Douek; Julie E Ledgerwood; Adrian B McDermott; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2020-07-02       Impact factor: 21.023

Review 6.  Deceptology in cancer and vaccine sciences: Seeds of immune destruction-mini electric shocks in mitochondria: Neuroplasticity-electrobiology of response profiles and increased induced diseases in four generations - A hypothesis.

Authors:  Mahin Khatami
Journal:  Clin Transl Med       Date:  2020-12

Review 7.  Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.

Authors:  Yaqin Bai; Jeremy C Jones; Sook-San Wong; Mark Zanin
Journal:  Viruses       Date:  2021-04-06       Impact factor: 5.048

8.  Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.

Authors:  Kevin R McCarthy; Tarra A Von Holle; Laura L Sutherland; Thomas H Oguin; Gregory D Sempowski; Stephen C Harrison; M Anthony Moody
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

Review 9.  Small Molecule Inhibitors of Influenza Virus Entry.

Authors:  Zhaoyu Chen; Qinghua Cui; Michael Caffrey; Lijun Rong; Ruikun Du
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

Review 10.  Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Authors:  Maya Sangesland; Daniel Lingwood
Journal:  Vaccines (Basel)       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.